36th Annual GRAL Conference
Course Goal
To promote international collaboration to further research on the diagnosis and treatment of age-related neurological disorders.
Course Learning Objectives
- To advance knowledge of brain function in normal and pathological aging
- To present strategies for health promotion and prevention of neurological disease/damage
- To demonstrate the trajectory of recovery from brain injury in aging individuals
- To characterize cognitive and functional decline in individuals with age-related neurodegenerative disease
- To promote understanding of novel therapeutic interventions for age-related neurological disease
Registration Information
| Attendee Type | price |
|---|---|
| Registration for 3 Days | $450 |
| Registration for 2 Days | $350 |
| Registration for 1 Day | $250 |
In-Person
January 29-31, 2025
Phoenix, Arizona
Date, Time, and Location
In Person
Wednesday – Friday, January 29-31, 2025
Barrow Neurological Institute
2910 North 3rd Avenue
Phoenix, Arizona 85013
Scroll down for campus map
Target Audience
This program is designed for physicians, neuropsychologists, psychologists, neuroscience researchers, physician assistants, and nurse practitioners.
Agenda & Speaker Information
| Time | Topic | speaker |
|---|---|---|
| Day One: Wednesday, Jan. 29 | Opening Ceremony | |
| 1:00 PM | Welcome to GRAL 2025 | Danielle Eagan, PhD |
| 1:05 PM | Welcome to Barrow Neurological Institute | Michael T. Lawton, MD |
| 1:10 PM | A Brief History of GRAL | Drs. Bernard Michel & Bernard Diadema, with translation by Yonas Geda, MD |
| 1:20 PM | The Role of Barrow on the Global Stage | Yonas Geda, MD |
| 1:30 PM | TBD | Bruce Price, MD |
| 2:05 PM | TBD | Gregory Jicha, MD, PhD |
| 2:25 PM | Factors Affecting WM Health Over the Lifespan | Christopher Filley, MD |
| 2:45 PM | TBD | Gustavo Roman, MD, DrHC |
| 3:05 PM | Is there a role of CSF-to-blood clearance for cognitive function? | Per Eide, MD, PhD |
| 3:25 PM | Questions | Moderator |
| 3:35 PM | Cognitive Function and Progression Of Cognitive Decline in a Norwegian MCI Population | Dr. Susan Hernes |
| 3:55 PM | Quality of Life of Patients with MCI and Their Relatives in Norway | Dr. Trine Holt Edwin |
| 4:15 PM | Epidemiology of MCI in Low- and Middle-Income Countries | Dr. Gizachew Yismaw Webetu |
| 4:35 PM | Use of Digital Tools in Dementia Diagnostics | Dr. Anne Brita Knapskog |
| 4:55 PM | Questions | Moderator |
| 5:05 PM | Adjourn | |
| 6:00 PM – 8:00 PM | Reception at Phoenix Art Museum | |
| Day Two: Thursday, Jan. 30 8:00 AM | Coffee and Breakfast | |
| 8:30 AM | TBI & Aging | Dr. Michael Alosco |
| 8:50 AM | Traumatic Brain Injury in Aging Populations | Javier Cárdenas, MD |
| 9:10 AM | Cerebellum in mTBI | Dr. Bernard Michel |
| 9:30 AM | Questions | Moderator |
| 9:40 AM | Neuropsychiatric Manifestations in Parkinson’s and Dementia with Lewy Bodies | Holly Shill, MD |
| 10:00 AM | Pain and Other Non-Motor Symptoms in Parkinson’s Disease | Dr. Oury Monchi |
| 10:20 AM | Cognition in NPH | Justin Hoskin, MD |
| 10:40 AM | Questions and Coffee Break | Moderator |
| 11:05 AM | Epilepsy and the Aging Brain | Dr. Mohamad Koubeissi |
| 11:25 AM | Epilepsy & Aging/Diet and Recovery after Surgery | Kris Smith, MD |
| 11:45 AM | Aging with Epilepsy: Chronic Effects of Seizures, Medications, and Neurosurgeries on Cognition | Will Schultz, PhD |
| 12:15 PM | Questions | Moderator |
| 1:15 PM | Lunch and Poster Session | |
| 1:45 PM | Language Recovery after Stroke | Dr. Andrew DeMarco |
| 2:05 PM | Language Structure and its Deterioration in Neurodegenerative Diseases Affecting Cognition | Marc Teichmann, MD |
| 2:25 PM | TBD | Neguine Rezaii, MD |
| 2:45 PM | Questions | Moderator |
| 2:55 PM | Cognitive Intervention in Prodromal Alzheimer’s and At-Risk Older Adults: From Efficacy to Implementation | Dr. Sylvie Beleville |
| 3:15 PM | Performing Arts as a Non-Pharmacological Intervention for Alzheimer’s Patients | Dr. Anne-Marie Ergis |
| 3:35 PM | Disorders of Consciousness, Neurorecovery and Neuroethics | Dr. Michael Young |
| 3:55 PM | Telerehabilitation among Older Adults | Dr. Nicoletta Caputi |
| 4:15 PM | Questions | Moderator |
| 4:25 PM | Adjourn | |
| Day Three: Friday, Jan. 31 8:00 AM | Coffee and Breakfast | |
| 8:30 AM | Results of the SMELTER Study | Brad Racette, MD |
| 9:40 AM | The Role of Barrow Global | Dilan Ellegala, MD |
| 10:00 AM | The Design of a Population-Based Study of Dementia in the Vicinity of the Source of the Blue Nile River | Dr. Muluken Azage Yenesew |
| 10:20 AM | Integrating Dementia Research in a Demographic and Health Surveillance Center in Southern Ethiopia | Dr. Alemu Tamiso Debiso |
| 10:40 AM | The Birth of Neuroscience in Ethiopia: A Pioneering Legacy | Dr. Muluken Tesfaye |
| 11:00 AM | Questions and Coffee Break | Moderator |
| 11:15 AM | A Shift from Western to African Cognitive Assessment of Alzheimer’s Disease | Dr. Jean Ikanga |
| 11:35 AM | Global Neurology Training: Embracing Diversity for a Stronger Future | Huiam Mubarak, MD |
| 11:55 AM | TBD | Dr. Adesola Ogunniyi |
| 12:15 PM | Questions | Moderator |
| 12:25 PM | Lunch and Poster Session | |
| 1:25 PM | Poster Session and Vendor Hall | |
| 1:55 PM | Drugs in Development for Alzheimer’s Disease | Marwan Sabbagh, MD |
| 2:15 PM | Alzheimer’s Disease: A Disconnection Syndrome or Amyloid Proteinopathy | Elliot Mufson, PhD |
| 2:35 PM | Motor Correlates of Finger Tapping Variability in Subjective Memory Complaints, Mild Cognitive Impairment, and Alzheimer’s Disease | George Prigatano, PhD |
| 2:55 PM | Glucagon-Like Peptide 1: Possible Implications for Neuropsychiatry and Neurodegenerative Disorders | Anna Burke, MD |
| 3:15 PM | Molecular Targets of Potential Therapeutics for Frontotemporal Dementia | Dejarra Johnson, MD |
| 3:35 PM | What is Alzheimer’s disease and how to diagnose it? | Dr. Bruno Dubois |
| 3:55 PM | Questions | Moderator |
| 4:00 PM | Adjourn |
International Scientific Committee
Bernard Francois Michel, MD
President, Groupe de Recherche sur la maladie d’Alzheimer (GRAL)
Chief Medical Officer Neurologist
Professor Aix-Marseille University, France
Yonas E. Geda, MD, MSc
Vice President, Groupe de Recherche sur la maladie d’Alzheimer (GRAL)
Professor and Program Director, Behavioral Neurology & Neuropsychiatry Fellowship Program, Barrow Neurological Institute
Francois Boller, MD, PhD
Clinical Professor of Neurology and Rehabilitation Medicine
George Washington School of Medicine & Health Sciences, Washington DC
Nicoletta Caputi, PhD
Fellow at George Washington University and University of L’Aquila, Italy
Ann-Marie Ergis, PhD
Professor at Paris Descartes, CPSC, France
Gabor G. Kovacs, MD, PhD
Professor in the Department of Laboratory Medicine & Pathobiology
University of Toronto, Canada
Bruce Price, MD
Chief, Department of Neurology, McLean Hospital, Belmont Massachusetts
Exhibitors and Sponsors
- Exhibitor and sponsor information coming soon.
Location
